Holen Sie sich die Stockscreener-App
436.13
0.91%
4.1319
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$432.00
Offen:
$434.73
24-Stunden-Volumen:
274.72K
Relative Volume:
0.19
Marktkapitalisierung:
$98.20B
Einnahmen:
$176.81B
Nettoeinkommen (Verlust:
$5.98B
KGV:
17.03
EPS:
25.61
Netto-Cashflow:
$4.55B
1W Leistung:
+2.04%
1M Leistung:
+9.84%
6M Leistung:
-16.16%
1J Leistung:
-15.93%
1-Tages-Spanne:
$431.04
$437.07
1-Wochen-Bereich:
$419.53
$437.07
52-Wochen-Spanne:
$362.21
$567.26
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Vergleichen Sie ELV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
436.28 | 98.20B | 176.81B | 5.98B | 4.55B | 25.61 |
|
UNH
Unitedhealth Group Inc
|
522.18 | 476.52B | 400.28B | 14.41B | 20.71B | 15.50 |
|
CI
Cigna Group
|
329.77 | 89.74B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
67.58 | 85.19B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
263.32 | 32.63B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Here’s Why Elevance Health (ELV) Declined in Q4 - Yahoo Finance
Elevance Health, Inc. (NYSE:ELV) Shares Bought by CIBC Private Wealth Group LLC - MarketBeat
Artisan Partners Limited Partnership Boosts Stake in Elevance Health, Inc. (NYSE:ELV) - MarketBeat
Insiders At Elevance Health Sold US$12m In Stock, Alluding To Potential Weakness - Yahoo Finance
High Ground Investment Management LLP Has $77.10 Million Position in Elevance Health, Inc. (NYSE:ELV) - MarketBeat
Form DEF 14A Elevance Health, Inc. For: May 14 - StreetInsider.com
Bernstein raises Elevance stock target to $585 on EPS growth outlook - Investing.com India
Is Elevance Health, Inc.'s (NYSE:ELV) Latest Stock Performance A Reflection Of Its Financial Health? - Simply Wall St
What Gives Elevance Health (ELV) an Attractive Opportunity in The Large Cap Space? - Insider Monkey
Bernstein Adjusts Price Target on Elevance Health to $585 From $511, Keeps Outperform Rating - Marketscreener.com
Here's How Much $100 Invested In Elevance Health 15 Years Ago Would Be Worth Today - Benzinga
Elevance Fails To Pay Wages At Termination, Worker Says - Law360
Healthcare Disruptors: AI, Telehealth and Cost Savings - Value the Markets
Elevance Enjoys Local Market Leadership in Medical Insurance - Morningstar
Elevance Health (ELV): Company Profile, Stock Price, News, Rankings - Fortune
Is Elevance Health, Inc. (NYSE:ELV) Potentially Undervalued? - Yahoo Finance
Is Elevance Health, Inc. (ELV)The Best Healthcare Dividend Stock to Invest in? - Insider Monkey
How Do Investors Really Feel About Elevance Health? - Benzinga
Is UnitedHealth Stock Still a Buy Despite Its Premium Price Tag? - TradingView
Elevance Reaches $3.3M Deal to Settle Lawsuit Over Denied Spinal Surgery Coverage - USA Herald
Elevance Inks $3.3M Deal To End Surgery Claim Denial Suit - Law360
Elevance Settles Joint Fusion Surgery Lawsuit for $2.5 Million - Bloomberg Law
Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock? - TradingView
Argus Research Upgrades Elevance Health to Buy, $450 Price Target -March 17, 2025 at 07:58 am EDT - Marketscreener.com
Investing in Elevance Health (NYSE:ELV) five years ago would have delivered you a 134% gain - Yahoo Finance
Elevance Health’s Whole Health Index Demonstrates Opportunity to Improve Health - Business Wire
Elevance Health Foundation Exceeds $90 Million Goal to Advance Health Equity and Strengthen Communities - Business Wire
Elevance Health (NYSE:ELV) Rating Lowered to “Hold” at StockNews.com - Defense World
Trade Alert: Executive VP & President of Commercial Health Benefits Of Elevance Health Charles Kendrick Has Sold Stock - Simply Wall St
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio (NYSE:ELV) - Seeking Alpha
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 15 Years - Benzinga
Elevance Health, Inc. (NYSE:ELV): Waning Industry Headwinds to Boost Performance - MSN
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength? - Nasdaq
Is Elevance Health, Inc.'s (NYSE:ELV) Stock's Recent Performance A Reflection Of Its Financial Health? - Yahoo Finance UK
Augusta Health, Anthem Blue Cross and Blue Shield Announce Multi-Year Contract - Augusta Health
Is Elevance Health, Inc. (ELV) the Top Health Insurance Stock to Buy Now? - Insider Monkey
Elevance Health stock gains on CFO comments (ELV:NYSE) - Seeking Alpha
Elevance Health gains after CFO comments at investor event - MSN
Elevance Health (NYSE:ELV) stock performs better than its underlying earnings growth over last five years - Simply Wall St
Rep. Jefferson Shreve Purchases Shares of Elevance Health, Inc. (NYSE:ELV) - Defense World
Elevance Health confirms 2025 earnings forecast By Investing.com - Investing.com South Africa
Elevance Health Expects FY Adjusted Earnings Of $34.15-$34.85 Per Share -March 10, 2025 at 05:40 pm EDT - Marketscreener.com
Elevance Health confirms 2025 earnings forecast - Investing.com
Elevance Health Reaffirms 2025 Earnings Guidance to Investors - TipRanks
Elevance Health, Inc. (NYSE:ELV) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt - Yahoo Finance
Top 10 Health Insurance Stocks To Buy - Insider Monkey
May 16th Options Now Available For Elevance Health (ELV) - Nasdaq
M&T Bank Corp Sells 1,744 Shares of Elevance Health, Inc. (NYSE:ELV) - MarketBeat
LGT Group Foundation Trims Stock Holdings in Elevance Health, Inc. (NYSE:ELV) - MarketBeat
Elevance Health Stock: Is ELV Underperforming the Healthcare Sector? - Nasdaq
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):